Saturday 17 October 2026
Export RVP’s income statement to Excel — free account
Retractable Technologies, Inc.
RVP Healthcare Medical Instruments & Supplies
Retractable Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.3 million, up 15.8% from fiscal 2024. In the quarter to June 2026, revenue fell 31.1%, EPS was flat, free cash flow grew 56.7% and total debt fell 32.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.58
0.01
−1.69%
Follow RVP
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(8.36%) | (15.89%) | (8.92%) | (4.84%) | |
Piotroski F-Score |
4 | 5 | 5 | 4 | |
| (4.39%) | (8.44%) | (4.55%) | (2.49%) | ||
ROIC |
(29.50%) | (34.56%) | (40.15%) | (42.05%) | |
Return on Tangible Assets |
(4.88%) | (9.65%) | (5.14%) | (2.81%) | |
Average Days of Receivables |
87.64 | 78.33 | 71.59 | 100.53 | |
Free Cash Flow per Share |
(0.28) | (0.25) | (0.25) | (0.17) | |
Free Cash Flow |
(8.38) | (7.60) | (7.41) | (5.11) | |
Capital Expenditures |
(0.81) | (0.54) | (0.45) | (0.15) | |
| Other line items | |||||
Cash ROIC |
(7.50%) | (6.77%) | (6.96%) | (4.50%) | |
Accounts Receivable Turnover |
4.01 | 4.51 | 5.57 | 3.75 | |
Accounts Payable Turnover |
9.92 | 7.94 | 7.51 | 6.39 | |
Inventory Turnover |
1.86 | 2.10 | 2.02 | 1.89 | |
Average Days of Payables |
43.02 | 51.00 | 51.80 | 71.11 | |
Days of Inventory on Hand |
191.71 | 164.15 | 158.09 | 169.09 | |
Tax Rate |
0.05 | 0.02 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1.87% | 1.77% | 1.76% | 2.01% | |
Selling, General and Administrative Expense of Revenue |
50.28% | 51.20% | 54.56% | 60.62% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(222.15) | (240.63) | (266.98) | (278.98) | |
Operating CF/Net income |
1.13 | 0.55 | 1.07 | 1.38 | |
Depreciation/Fixed assets |
0.09 | 0.10 | 0.10 | 0.10 | |
Capex/Depreciation |
(0.11) | (0.07) | (0.06) | (0.02) | |
Revenue per Share |
1.27 | 1.28 | 1.24 | 1.13 | |
Operating CF per Share |
(0.25) | (0.24) | (0.23) | (0.17) | |
Capex per Share |
(0.03) | (0.02) | (0.02) | (0.01) | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.00 |
Columns are period end dates